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Activation of the epidermal growth factor receptor (EGFR) not only initiates multiple signal-
transduction pathways, including the mAP kinase (mAPK) pathway, but also triggers trafficking 
events that relocalize receptors from the cell surface to intracellular endocytic compartments. In 
this paper, we demonstrate that leucine-rich repeat kinase LRRK1, which contains a mAPKKK-
like kinase domain, forms a complex with activated EGFR through an interaction with Grb2. 
subsequently, LRRK1 and epidermal growth factor (EGF) are internalized and co-localized in 
early endosomes. LRRK1 regulates EGFR transport from early to late endosomes and regulates 
the motility of EGF-containing early endosomes in a manner dependent on its kinase activity. 
Furthermore, LRRK1 serves as a scaffold facilitating the interaction of EGFR with the endosomal 
sorting complex required for transport-0 complex, thus enabling efficient sorting of EGFR to the 
inner vesicles of multivesicular bodies. our findings provide the first evidence that a mAPKKK-
like protein regulates the endosomal trafficking of EGFR. 
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B
inding of epidermal growth factor (EGF) to its cell surface 
receptor (EGFR) results in the activation of numerous cell sig-
nalling pathways essential for cellular proliferation, survival 
and differentiation. Activation of EGFR also initiates events lead-
ing to its endocytosis1,2. Receptors, once internalized, are delivered 
to the endosomal system, from where they are either recycled to 
the cell surface or sorted to lysosomes for degradation3–5. Endocytic 
trafficking serves as an important determinant of the intensity and 
duration of EGFR signalling.
Recent  studies  have  shown  that  the  endosomal  sorting  com-
plexes required for transport, ESCRT-0, -I, -II and -III, are involved 
in  the  endosomal  sorting  of  ubiquitinated  EGFR  to  lysosomes 
through multivesicular bodies (MVBs)6–10. The ESCRT-0 complex, 
which is composed of hepatocyte growth factor-regulated substrate 
(Hrs) and signal-transducing adaptor molecule (STAM), is believed 
to initiate the process by which EGFR is targeted to lysosomes at 
the early endosome stage. This targeting involves the clustering of 
ubiquitinated EGFR underneath a clathrin microdomain by recruit-
ing the ESCRT-I complex to the surface of endosomes. Binding of 
ESCRT-I to the surface of endosomes leads to the sequential recruit-
ment  of  ESCRT-II  and  ESCRT-III  complexes.  These  complexes 
function sequentially in the formation of MVB vesicles and in the 
sorting of EGFR into the MVB pathway. Thus, the recognition of 
EGFR by the ESCRT-0 complex is a critical step in the sorting of 
EGFR to lysosomes.
Human LRRK1 and LRRK2 belong to the ROCO family of pro-
teins and contain a Roc (Ras in complex proteins) domain together 
with a MAPKKK-like kinase domain and several protein–protein   
interaction  domains.  Recently,  LRRK2  has  been  reported  to  be 
involved  in  the  pathogenesis  of  familial  Parkinson’s  disease11,12. 
However, the functions of LRRK1 and LRRK2 remain unknown.
In this study, we identified Grb2, which is known to be essential 
for EGFR signalling and endocytosis1,13–16, as an LRRK1-interacting 
protein. We demonstrate that LRRK1 participates in the intracellu-
lar trafficking of EGFR through an interaction with Grb2. Our find-
ings indicate that LRRK1 regulates transport and sorting of EGFR 
in a manner dependent on and independent of its kinase activity, 
respectively.
Results
LRRK1  forms  a  complex  with  activated  EGFR  via  Grb2.  To 
investigate  the  physiological  roles  of  LRRK1,  we  attempted  to   
identify  molecules  with  which  it  interacts.  We  used  liquid 
chromatography-coupled  tandem  mass  spectrometry  (LC–MS/
MS)17, and identified multiple peptides (Supplementary Table S1). 
Among the proteins identified, we focused on the Grb2 protein. To 
confirm the association between LRRK1 and Grb2, COS7 cells were 
co-transfected with Flag-LRRK1 and HA-Grb2. As seen in Figure 1a, 
Flag-LRRK1 associated with HA-Grb2. This association was specific 
for LRRK1, because LRRK2 did not interact with Grb2 (Fig. 1a).
Grb2  contains  a  single  SH2  domain  flanked  by  two  SH3 
domains14.  We  examined  whether  the  SH2  or  SH3  domain  is 
required for interaction with LRRK1. Mutations in the amino (N)-
terminal SH3 (P49L) or SH2 (S90N) domain of Grb2 had no effect 
on its interaction with LRRK1 (Fig. 1a). In contrast, a mutation in 
its carboxy (C)-terminal SH3 domain (G203R) resulted in the loss 
of detectable binding to LRRK1 (Fig. 1a). Thus, interaction of Grb2 
with  LRRK1  requires  the  C-terminal  SH3  domain  of  Grb2.  We 
next examined which region of LRRK1 is required for its associa-
tion with Grb2. We constructed several deletion mutants of LRRK1 
(Fig. 1b) and analysed their binding to Grb2. C-terminal-deleted 
mutants LRRK1(1–1163) and LRRK1(1–595), but not the N-termi-
nal-deleted mutant LRRK1(1164–1989), bound to Grb2 (Supple-
mentary Fig. S1). It is known that the SH3 domain of Grb2 binds 
to the proline-based motif PXXP14. As the LRRK1(1–595) fragment 
contains two PXXP motifs, which are located at residues 88–91 and 
119–122 (Fig. 1b), we examined whether these sites are responsible 
for Grb2 association. We found that mutation of the Pro residues 
in both PXXP motifs to Ala (mutant LRRK1(P88A/P91A/P119A/
P122A); LRRK1(4PA)) eliminated binding to Grb2 (Fig. 1c). These 
results indicate that LRRK1 associates with Grb2 through an inter-
action between the PXXP motifs of LRRK1 and the C-terminal SH3 
domain of Grb2. Using a polyclonal anti-LRRK1 antibody that we 
generated (Supplementary Fig. S2), we also investigated the interac-
tion of endogenously expressed LRRK1 and Grb2. We found that 
endogenous LRRK1 was able to associate with endogenous Grb2 in 
a ligand-independent manner (Fig. 1d).
Because Grb2 functions as an adaptor protein facilitating the 
association of several factors with activated EGFR14,15, we examined 
whether LRRK1 forms a complex with EGFR in response to EGF 
stimulation.  COS7  cells  were  transfected  with  GFP-LRRK1.  We 
found that GFP-LRRK1 bound to EGFR in a stimulus-dependent 
manner (Fig. 1e). In contrast, the Grb2-binding-defective mutant 
GFP-LRRK1(4PA) was unable to associate with EGFR after EGF 
stimulation (Fig. 1e), suggesting that Grb2 mediates the interaction 
between LRRK1 and EGFR. We also found that endogenous LRRK1 
was able to form a complex with EGFR following EGF stimulation 
(Fig. 1f). Furthermore, when cells were depleted of Grb2 by trans-
fection with small interfering RNA (siRNA), LRRK1 was unable to 
interact with EGFR in response to EGF stimulation, regardless of 
where endogenous or overexpressed LRRK1 was used (Fig. 1f; Sup-
plementary Fig. S3). Taken together, these results demonstrate that 
LRRK1 forms a complex with EGFR in response to EGF stimulation 
in a Grb2-dependent manner.
LRRK1 co-localizes with EGF in early endosomes. To investigate 
the role of LRRK1 in EGFR signalling, we examined the subcellular 
localization of LRRK1. Because our polyclonal anti-LRRK1 antibody 
did not provide a sensitive enough detection of the endogenous 
protein by immunostaining, we used an epitope-tagged LRRK1. We 
expressed GFP-LRRK1 in HeLa cells and assessed LRRK1 localiza-
tion by immunofluorescence under basal and EGF-stimulated con-
ditions, together with a fluorescently labelled rhodamine-conjugated 
EGF (EGF-Rh). LRRK1 was diffusely distributed in cells not treated 
with EGF-Rh (Fig. 2a). When cells were stimulated with EGF-Rh 
for 15 min, GFP-LRRK1 became distributed in a fine, punctate pat-
tern that co-localized with EGF-Rh. A large portion of GFP-LRRK1 
overlapped with the early endosomal marker autoantigen 1 (EEA1) 
receptor (Fig. 2b; Supplementary Fig. S4).
We next analysed the ability of Grb2 to affect the intracellular 
localization of LRRK1 in EGF-stimulated cells. When Grb2 was 
depleted from HeLa S3 cells using siRNA, EGF-induced localization 
of LRRK1 in EEA1-positive early endosomes was greatly decreased 
(Fig.  2c,d;  Supplementary  Fig.  S5a).  This  suggests  that  Grb2  is 
required  for  the  EGF-induced  translocation  of  LRRK1  to  early 
endosomes. Consistent with this, LRRK1(4PA), which is defective 
for Grb2 binding, failed to localize to early endosomes in response 
to EGF stimulation (Fig. 2e; Supplementary Fig. S5b). Thus, EGF-
induced localization of LRRK1 to early endosomes is dependent on 
Grb2-mediated complex formation with activated EGFR.
LRRK1 regulates EGFR transport from early to late endosomes. 
Given  the  EGF-dependent  association  of  LRRK1  with  the  early 
endosome, we reasoned that LRRK1 might function by affecting 
the endocytic trafficking of EGFR. To test this idea, we monitored 
the endocytic movement of EGF in cells depleted of LRRK1 by 
siRNA. HeLa S3 cells incubated with LRRK1 siRNA had a much 
lower expression of LRRK1 (Supplementary Fig. S6). HeLa S3 cells 
treated with control or LRRK1 siRNA were stimulated with fluores-
cent EGF (Alexa 647-EGF) briefly, followed by washing to remove 
labelled EGF from the medium. Under these conditions, the fluo-
rescence detected in cells was due to endocytosed EGFR bound to ARTICLE     
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labelled growth factor. In LRRK1-depleted cells, the initial localiza-
tion of EGF to clathrin-coated pits occurred normally, similar to 
control cells (Supplementary Fig. S7). Thus, depletion of LRRK1 has 
little obvious effect on the internalization of EGF/EGFR.
Because it is known that Rab5 and Rab7 primarily associate with 
early and late endosomes, respectively, we coexpressed GFP-Rab5 
and DsRed-Rab7 in HeLa S3 cells to visualize early and late endo-
somes. In this experiment, we used the monomer version of DsRed. 
Most of the Rab5-positive endosomes were distributed in the cell 
periphery, whereas Rab7-positive endosomes were more common 
in the perinuclear region (Fig. 3a–d). In control siRNA-transfected 
cells, at 10 min after a brief pulse of Alexa 647-EGF stimulation, 
most of the EGF was found in early endosomes, as evidenced by 
their co-localization with Rab5 (Fig. 3a,e; Supplementary Fig. S8a).   
After 15 min, EGF dissociated from the early endosomes, as illus-
trated  by  decreased  co-localization  with  Rab5.  Remarkably,  this 
decreased  co-localization  with  Rab5  was  accompanied  by  an 
increase in the co-localization with Rab7 (Fig. 3b,e and f; Sup-
plementary Fig. S8b), suggesting the progression of EGFR to the 
late-endosomal compartments. In LRRK1-depleted cells, the early 
endosomal localization of EGF occurred normally, as in control 
cells (Fig. 3c,e; Supplementary Fig. S8c). However, after 15 min of 
stimulation, Alexa 647-EGF remained associated with Rab5-posi-
tive structures and Rab7 co-localization did not increase (Fig. 3d–f; 
Supplementary Fig. S8d). This suggests that the transport of EGFR 
towards late endosomes is inhibited in LRRK1-deficient cells. Thus, 
LRRK1 is required for the progression of EGFR from early to late 
endosomes.
LRRK1 regulates the motility of EGF-early endosomes. Because 
maturation of early to late endosomes is accompanied by the move-
ment of endosomes towards the cell centre18–20, we examined the 
effect of LRRK1 knockdown on the movement of EGF-containing 
early  endosomes.  Using  time-lapse  confocal  fluorescence  micro-
scopy,  movement  of  EGF-containing  early  endosomes  was  fol-
lowed in cells expressing GFP-Rab5 at 15 min after a brief pulse of 
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Figure 1 | LRRK1 forms a complex with EGFR via Grb2 in response to EGF stimulation. (a) Interaction of LRRK1 with Grb2. Cos7 cells were  
co-transfected with Flag-LRRK1, Flag-LRRK2 and HA-Grb2 (wild type (WT), P49L, s90n, G203R and P49L/G203R mutants), as indicated. Complex 
formation was detected by immunoprecipitation (IP) with anti-HA antibodies, followed by immunoblotting (Blot) with anti-Flag antibodies.  
(b) Comparison of LRRK1 and LRRK2 structures. schematic diagrams of human LRRK1 and LRRK2 proteins are shown. Domains are shown as follows: 
leucine-rich repeats (LRR), a Roc domain, a Cor domain, a mAPKKK-like kinase domain and WD40 repeats. The sequence alignment of LRRK1 and H-Ras 
in the Roc domain and of LRRK1 and mixed-lineage kinase 1 (mLK1) in the kinase domain are shown. Identical residues are highlighted with black shading. 
Arrowheads indicate amino-acid substitutions used in this study. Deletion constructs of LRRK1 are shown below. Two PXXP motifs within LRRK1(1–595) 
are shown by the arrowheads. (c) Effect of the 4PA mutation on the interaction of LRRK1 with Grb2. Cos7 cells were co-transfected with GFP-LRRK1 (wild 
type and the 4PA mutant) and HA-Grb2, as indicated. Complex formation was detected by immunoprecipitation (IP) with anti-HA antibodies, followed 
by immunoblotting (Blot) with anti-GFP antibodies. (d) Interaction of endogenous LRRK1 with endogenous Grb2. Complex formation in HEK293 cells was 
detected by immunoprecipitation (IP) with anti-Grb2 antibodies, followed by immunoblotting (Blot) with anti-LRRK1 antibodies. LC, light chain. (e) Effect 
of the 4PA mutation on the interaction of LRRK1 with activated EGFR. Cos7 cells were transfected with GFP-LRRK1 (wild type and the 4PA mutant). After 
16 h of serum starvation, cells were stimulated with 100 ng per ml of EGF. Complex formation was detected by immunoprecipitation (IP) with anti-GFP 
antibodies, followed by immunoblotting (Blot) with anti-phospho-tyrosine (pTyr) antibodies. (f) Interaction of endogenous LRRK1 with endogenous EGFR. 
HEK293 cells treated with control or Grb2 siRnA were serum starved and stimulated with 100 ng per ml of EGF. Complex formation was detected by 
immunoprecipitation (IP) with anti-EGFR antibodies, followed by immunoblotting (Blot) with anti-LRRK1 antibodies.ARTICLE
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Alexa647-EGF. In addition to short-range movement, long-range 
rapid movement of EGF-positive early endosomes from the periph-
ery to the centre was frequently observed (Fig. 4a,b). When LRRK1 
was knocked down by siRNA, long-range rapid movement of EGF-
containing early endosomes was remarkably disrupted (Fig. 4c,d). In 
control cells, 39.7% of GFP-Rab5- and Alexa 647-EGF-double-posi-
tive endosomes moved more than 3.0 µm during the imaging time 
(35 s), but this fraction decreased to only 2.4% in LRRK1-depleted 
cells (Fig. 4e). We further confirmed this effect of knocking down 
LRRK1 on the frequency of long-range movement of EGF using a 
different LRRK1 siRNA in different HeLa cell lines (Supplementary 
Fig. S9). These observations suggest that LRRK1 is required for the 
motility of EGF-containing early endosomes.
The role of Roc and kinase domains in EGFR trafficking. Ras 
proteins switch between an inactive GDP-bound state and an active 
GTP-bound state and only the latter interacts with its downstream 
effectors. Among the best characterized downstream effectors of 
Ras are the MAPKKKs21. Members of the ROCO protein family 
contain a Ras GTPase-like (Roc) domain and a MAPKKK domain 
(Fig.  1b).  The  Roc  domain  likely  serves  as  a  molecular  switch,   
regulating  kinase  activity  by  cycling  between  GDP-bound  and   
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Figure 2 | LRRK1 co-localizes with EGF in early endosomes. (a,b) Co-localization of LRRK1 with EGF in EEA1-labelled early endosomes. HeLa cells were 
transfected with GFP-LRRK1. After 16 h of serum starvation, cells were incubated without (a) or with (b) 50 ng per ml of EGF-Rh (red) for 45 min at 4°C, 
followed by warming for 15 min at 37°C, and stained with anti-EEA1 antibodies (blue). All cells were imaged by confocal microscopy. The boxed regions 
are magnified in insets. Examples of co-localization of GFP-LRRK1, EGF-Rh and EEA1 are indicated with arrowheads (supplementary Fig. s4). scale bar, 
10 µm. (c, d) Effect of Grb2 depletion on LRRK1 localization in early endosomes. HeLa s3 cells treated with control (c) or Grb2 siRnA (d) were transfected 
with GFP-LRRK1. After 16 h of serum starvation, cells were stimulated with 100 ng per ml of EGF for 15 min. The cells were fixed, stained with anti-EEA1 
antibodies and imaged by confocal microscopy. Yellow colour in the merged images indicates co-localization. scale bar, 10 µm. (e) Effect of 4PA mutation 
on LRRK1 localization. HeLa cells were transfected with GFP-LRRK1(4PA). After 16 h of serum starvation, cells were incubated with 50 ng per ml of  
EGF-Rh (red) for 45 min at 4°C, followed by warming for 15 min at 37°C, and stained with anti-EEA1 antibodies (blue). All cells were imaged by confocal 
microscopy. scale bar, 10 µm.ARTICLE     
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GTP-bound states22–24. To test whether the Roc domain of LRRK1 
also  regulates  its  kinase  activity,  we  generated  LRRK1(S625N)   
(Fig. 1b), in which Ser-625 in the Roc domain of LRRK1 has been 
mutated to Asn, on the basis of homology to Ras25. We confirmed that   
the LRRK1(S625N) form lost the ability to bind to GTP sepharose 
(Supplementary Fig. S10a) and was defective in kinase activity, sim-
ilar to a kinase-inactive LRRK1(K1243M) (Fig. 1b; Supplementary 
Fig. S10b). These results are consistent with a model wherein the 
Roc domain regulates the activity of the kinase domain.
We next examined whether LRRK1(K1243M) or LRRK1(S625N) 
could rescue the defect in EGFR trafficking caused by LRRK1 knock-
down. A large fraction of EGF dissociated from early endosomes 
20 min  after  EGF-Rh  stimulation  in  control  siRNA-treated  cells 
(Supplementary Fig. S11a), whereas the EGF remained localized 
in early endosomes in LRRK1 siRNA-treated cells (Supplementary 
Fig. S11b), as evidenced by their co-localization with EEA1. Expres-
sion of siRNA-resistant wild-type GFP-LRRK1 in LRRK1-depleted 
cells decreased co-localization of EGF with EEA1 and somewhat 
enhanced the transport of EGF towards the cell centre at 20 min 
after  EGF-Rh  stimulation  (Supplementary  Fig.  S11c),  suggesting 
that EGF was localized in late endosomes. When siRNA-resistant 
GFP-LRRK1(K1243M) or GFP-LRRK1(S625N) was reintroduced 
into LRRK1-depleted cells, most of the EGF remained co-localized 
with EEA1 even after a chase of 20 min (Supplementary Fig. S11d,e).   
Furthermore, we found that siRNA-resistant wild-type GFP-LRRK1, 
but not GFP-LRRK1(K1232M), was able to rescue the movement 
of EGF in LRRK1-depleted cells (Supplementary Fig. S12). These 
results suggest that the kinase function of LRRK1 is required for the 
transport of EGF/EGFR from early to late endosomes.
The  relationship  between  LRRK1  and  the  ESCRT-0  complex. 
Trafficking of EGF/EGFR in early endosomes is initiated by the 
interaction of ubiquitinated EGFR with components of the ESCRT-
0  complex,  STAM  and  Hrs6–10.  To  determine  whether  the  effect 
of LRRK1 on EGFR trafficking involves these endosomal sorting 
components, we examined the interaction of LRRK1 with STAM 
and Hrs. COS7 cells were transfected with GFP-LRRK1 and stimu-
lated with EGF. Coimmunoprecipitation experiments revealed that 
LRRK1 associated with endogenous STAM1 and that this inter-
action was increased by EGF stimulation (Fig. 5a). Furthermore, 
we  found  that  endogenous  LRRK1  was  coimmunoprecipitated 
with endogenous Hrs in an EGF stimulation-dependent manner 
(Fig. 5b). These results demonstrate that LRRK1 interacts with the 
ESCRT-0 complex in response to EGF stimulation.
To  determine  which  regions  are  responsible  for  the  LRRK1–
STAM1  interaction,  we  constructed  several  deletion  mutants  of 
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Figure 3 | Depletion of LRRK1 inhibits EGFR transport from early to late endosomes. (a, b) HeLa s3 cells treated with control siRnA were co-transfected 
with GFP-Rab5 and DsRed-Rab7. After 16 h of serum starvation, cells were stimulated with 100 ng per ml of Alexa 647-EGF for 3 min at 37°C, followed 
by washing to remove labelled EGF from the medium. The cells were fixed at 10 min (a) and 15 min (b) after the initial exposure to Alexa 647-EGF and 
imaged by confocal microscopy. The boxed regions are magnified in insets. Arrowheads and arrows indicate co-localization of Alexa 647-EGF with 
GFP-Rab5 and DsRed-Rab7, respectively (supplementary Fig. s8). scale bar, 10 µm. (c, d) Effect of LRRK1 depletion on EGFR transport from early to late 
endosomes. HeLa s3 cells treated with LRRK1 siRnA (stealth#1) were co-transfected with GFP-Rab5 and DsRed-Rab7. After 16 h of serum starvation, 
cells were stimulated with 100 ng per ml of Alexa 647-EGF for 3 min at 37°C, followed by washing to remove labelled EGF from the medium. The cells 
were fixed at 10 min (c) and 15 min (d) after the initial exposure to Alexa 647-EGF and imaged by confocal microscopy. The boxed regions are magnified 
in insets. Arrowheads indicate co-localization of Alexa 647-EGF with GFP-Rab5 (supplementary Fig. s8). scale bar, 10 µm. (e, f) Quantification of co-
localization of EGFR with Rab5 (e) and Rab7 (f). Cells treated with control (blue) or LRRK1 siRnA (stealth#1) (red) were co-transfected with GFP-Rab5 
and DsRed-Rab7. After 16 h of serum starvation, cells were stimulated with 100 ng per ml of Alexa 647-EGF for 3 min at 37°C, followed by washing to 
remove labelled EGF from the medium. The cells were fixed at 10 min and 15 min after the initial exposure to Alexa 647-EGF. Data are presented as 
percentages of Rab5-labelled (e) or Rab7-labelled (f) Alexa647-EGF-containing vesicles out of the total number of Alexa647-EGF-containing vesicles per 
cell. Values reflect the mean s.d. of three independent experiments, with an average of ten cells scored per experiment.ARTICLE
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STAM1 (Fig. 5c). Coimmunoprecipitation assays showed that the 
coiled-coil  domain  of  STAM1  was  important  for  its  interaction 
with LRRK1 (Fig. 5d). We next tested whether the kinase function 
of LRRK1 would affect its interaction with STAM1. We found that 
Flag-STAM1  coimmunoprecipitated  with  GFP-LRRK1(K1243M) 
(Fig. 5e), indicating that LRRK1 kinase activity is not required for its 
association with STAM1. In addition, the Grb2-binding-defective 
mutant GFP-LRRK1(4PA) was also able to associate with STAM1 
(Fig. 5e), suggesting that different regions of LRRK1 interact with 
Grb2 and STAM1. We next examined whether LRRK1, EGFR and 
STAM1 exist in the same complex. Flag-STAM1 and Myc-LRRK1 or 
Myc-LRRK1(K1243M) were coexpressed in COS7 cells and ternary 
complex formation was investigated via two-step immunoprecipi-
tation. Both Myc-LRRK1 and Myc-LRRK1(K1243M) were able to 
form a ternary complex with EGFR and STAM1 in response to EGF 
stimulation (Fig. 5f), indicating that LRRK1 kinase activity is not 
required for formation of this ternary complex. Given the results 
showing that LRRK1 interacts with EGFR and the ESCRT-0 com-
plex, we reasoned that loss of LRRK1 should also result in decreased 
EGFR–ESCRT-0  complex  formation.  When  cells  were  treated 
with LRRK1 siRNA, we observed a reduction in the EGF-depend-
ent  interaction  of  activated  EGFR  with  Flag-STAM1  (Fig.  5g).   
Taken together, these results suggest that LRRK1, by interacting 
with  both  Grb2  and  the  Hrs–STAM1  complex  simultaneously,   
functions as a scaffolding protein linking activated EGFR to the 
ESCRT-0 complex.
To further evaluate the interaction between LRRK1 and STAM, 
we examined the potential co-localization of LRRK1 and STAM1 
in early endosomes. Previous studies have revealed that Hrs accu-
mulates in restricted microdomains on the endosome membrane, 
strongly  co-localizing  with  clathrin26–29.  By  contrast,  EEA1-con-
taining  regions  of  the  endosome  membrane  are  largely  devoid 
of  Hrs  and  clathrin.  To  study  these  endosomal  microdomains, 
HeLa S3 cells were transfected with a constitutively active form of 
Rab5(Q79L), to increase the fusion rate of endosomes30. High Rab5 
activity results in enlarged early endosomes on which microdo-
mains can be easily distinguished by confocal immunofluorescence 
microscopy26,27,29,31. STAM1 co-localized strongly with clathrin on 
the enlarged endosomes (Supplementary Fig. S13a), whereas there 
was little co-localization of STAM1 and EEA1 (Supplementary Fig. 
S13b). These results suggest that STAM1 participates together with 
Hrs in the sorting of ubiquitinated cargo in clathrin-coated micro-
domains of early endosomes. GFP-LRRK1 was mainly distributed 
to the cytosol in the absence of EGF stimulation (Fig. 6a). However, 
LRRK1 localization was restricted to the enlarged endosomes of 
EGF-treated cells, and we could detect a certain degree of localiza-
tion of GFP-LRRK1 to STAM1-positive microdomains (Fig. 6b). We 
also found that EGFR co-localized with STAM1 on Rab5(Q79L)-
induced enlarged endosomes after EGF stimulation (Fig. 6c). To 
investigate  whether  LRRK1  is  important  for  the  recruitment  of 
EGFR into STAM1-positive microdomains, we set out to study the 
relative localizations of EGFR and STAM1 in LRRK1-depleted cells. 
In such LRRK1-depleted cells, both EGFR and STAM1 could still 
be detected on endosomes. Interestingly, however, LRRK1-depleted 
endosomes appeared to show decreased co-localization of EGFR 
and STAM1 (Fig. 6d). Furthermore, this co-localization gradually 
increased at the later phase of EGF stimulation (Fig. 6e), indicat-
ing that LRRK1 depletion delays EGFR-STAM1 co-localization. We 
confirmed the effect of LRRK1 depletion on the co-localization of 
Alexa 647-EGF and STAM1 by three-dimensional reconstruction 
of confocal Z-stack images (Supplementary Fig. S14). These results 
suggest that LRRK1 determines the efficiency of recruitment by 
serving as a scaffolding function on the endosomal membrane to 
restrict EGFR localization to STAM-positive microdomains.
LRRK1  modulates  the  ubiquitination  status  of  STAM1.  The   
sorting  of  ubiquitinated  EGFR  is  initiated  by  the  recognition  of 
EGFR ubiquitin (Ub) moieties by the Ub-interacting motifs (UIMs) 
within Hrs and STAM10,32. Hrs and STAM themselves are also ubiq-
uitinated32,33, and a recent study has suggested that intramolecu-
lar binding between UIMs and Ub prevents Hrs from binding in 
trans to ubiquitinated EGFR32. We therefore examined the effect of 
LRRK1 knockdown on the ubiquitination status of STAM1. We co-
transfected HeLa S3 cells with Flag-STAM1 and HA-Ub. In control 
siRNA cells, we could detect weak ubiquitination of STAM1 and this 
ubiquitination was enhanced by EGF stimulation (Fig. 7a). Deple-
tion  of  LRRK1  resulted  in  hyper-ubiquitination  of  STAM1  (Fig. 
7a). Thus, depletion of LRRK1 results in the enhancement of Ub   
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Figure 4 | Depletion of LRRK1 inhibits the motility of EGF-containing 
early endosomes. (a) Images representing GFP-Rab5-positive endosomes 
containing Alexa 647-EGF (red circles) and tracks (yellow). HeLa s3  
cells treated with control siRnA were transfected with GFP-Rab5,  
pulse-labelled with Alexa 647-EGF. movement of GFP-Rab5-positive 
endosomes containing Alexa 647-EGF was observed by time-lapse 
confocal fluorescence microscopy and analysed using the ‘manual 
Tracking’ Image J plug-in. Imaging started at 15 min after the initial 
exposure to Alexa 647-EGF, with frames captured at 1.165 s intervals for 
35 s. scale bar, 10 µm. (b) stills from control cells (the boxed region in a). 
Arrowheads and arrows indicate the movement of GFP-Rab5-positive 
endosome containing Alexa 647-EGF. (c) Images representing GFP-
Rab5-positive endosomes containing Alexa 647-EGF (red circles) and 
tracks (yellow). HeLa s3 cells treated with LRRK1 siRnA (stealth#1) were 
transfected with GFP-Rab5, pulse-labelled with Alexa 647-EGF. movement 
of GFP-Rab5-positive endosomes containing Alexa 647-EGF was observed 
by time-lapse confocal fluorescence microscopy and analysed using the 
‘manual Tracking’ Image J plug-in. Imaging started at 15 min after the 
initial exposure to Alexa 647-EGF, with frames captured at 1.165 s intervals 
for 35 s. scale bar, 10 µm. (d) stills from LRRK1-depleted cells (the boxed 
region in c). (e) A mobility histogram of randomly selected Rab5- and  
EGF-double-positive endosomes from control (blue) or LRRK1-depleted 
cells (red). mobility is defined as the distance of the trajectory of 
endosomes during the 35 s observation period, quantified using the 
‘manual Tracking’ Image J plug-in. Values reflect the mean s.d. of  
five independent experiments, with an average of 30 Rab5- and  
EGF-double-positive endosomes scored per experiment.ARTICLE     
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modification in STAM1. We then examined the effect of LRRK1 over-
expression on the ubiquitination status of STAM1. We found that 
overexpression of LRRK1 inhibited ubiquitination of STAM1 (Fig. 
7b). In addition, overexpression of kinase-negative LRRK1(K1243M) 
was able to inhibit STAM1 ubiquitination (Fig. 7b), suggesting that 
LRRK1 kinase activity is not necessary for this reaction.
We next attempted to narrow down the region(s) where STAM1 
is ubiquitinated, using various deletion mutants of STAM1 (Fig. 5c).   
Ubiquitination  assays  revealed  that  the  N-terminal  Ub-binding   
domains  (VHS  and  UIM)  and  the  SH3  domain  of  STAM1  are 
important for monoubiquitination, and that the coiled-coil domain 
contains  the  majority  of  polyubiquitination  sites  in  STAM1   
(Fig. 7c). Thus, the coiled-coil domain of STAM1 is involved in   
both its interaction with LRRK1 and its ubiquitination, raising the 
possibility that LRRK1 inhibits STAM1 ubiquitination by associat-
ing with its coiled-coil domain.
The  coiled-coil  domain  in  STAM1  has  five  lysine  residues   
(Fig. 7d). To confirm the importance of the coiled-coil domain for 
STAM1 ubiquitination, we generated STAM1(5KR), in which all 
these five lysines have been mutated to arginines. STAM1(5KR) 
was  impaired  in  polyubiquitination  but  not  in  monoubiquitina-
tion (Fig. 7d). These results suggest that the lysine residues in the 
coiled-coil  domain  of  STAM1  are  polyubiquitinated.  The  above 
results suggested that LRRK1 affects the interaction between EGFR   
and STAM1 by modulating the ubiquitination status of STAM1. 
Consistent  with  this,  STAM1(5KR)  showed  an  increase  in  its   
interaction with activated EGFR compared with wild-type STAM1 
(Fig. 7e). Taken together, these results suggest that LRRK1 functions 
as a scaffolding protein linking activated EGFR to the ESCRT-0 
complex by suppressing the polyubiquitination of STAM1.
LRRK1 regulates sorting of EGF/EGFR into intraluminal vesi-
cles of MVBs. EGFR localized in clathrin-coated microdomains on 
endosomes is sorted into intraluminal vesicles (ILVs) within MVBs 
and delivered to lysosomes for degradation. We therefore examined 
whether LRRK1 knockdown affects the sorting of EGFR into ILVs 
of enlarged endosomes using three-dimensional reconstructions. In 
control siRNA-transfected cells, Alexa 647-EGF was translocated 
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from  the  limiting  membrane  to  ILVs  of  Rab5(Q79L)-induced 
enlarged endosomes at 30 min after EGF stimulation (Fig. 8a). In 
contrast, depletion of LRRK1 reduced the intraluminal transport 
of Alexa 647-EGF into enlarged endosomes (Fig. 8b). Line inten-
sity profiles of individual endosomes clearly showed that most of 
the EGF was localized within the inner membranes in control cells 
(Fig. 8c), but were retained in the limiting membrane in LRRK1-
depleted cells (Fig. 8d). Quantification of EGF labelling showed that 
about 66.2% of the labelling was localized to the inner membranes 
in cells treated with control siRNA, whereas only 16.7% showed 
this localization in cells treated with LRRK1 siRNA (Fig. 8e). These 
results demonstrate that LRRK1 is needed for sorting of EGF/EGFR 
into ILVs of MVBs. When siRNA-resistant, wild-type GFP-LRRK1 
was expressed in LRRK1-depleted cells, the defect in the intralu-
minal transport of Alexa 647-EGF was partially rescued (Fig. 8e). 
However, expression of the siRNA-resistant, kinase-negative GFP-
LRRK1(K1243M) was able to rescue the defect in EGF sorting in 
LRRK1-depleted cells (Fig. 8e), suggesting that LRRK1 kinase activ-
ity is not essential for this step. Thus, LRRK1 functions as a scaffold 
in this process, independent of its kinase activity.
We confirmed the above immunofluorescence data by electron 
microscopy. Silver-enhanced gold particles revealed the presence 
of endogenous EGFR associated with both the limiting membrane 
and ILVs of MVBs in control cells, whereas most of the EGFR was 
still located on the limiting membrane of MVBs in LRRK1-depleted 
cells (Fig. 8f). We next asked whether LRRK1 could also affect EGFR 
degradation. Although EGF stimulation normally causes the deg-
radation of EGFR, we observed stabilization of activated EGFR in 
cells treated with LRRK1 siRNA (Fig. 8g). These results suggest that 
LRRK1 is required for EGFR sorting into the degradative pathway.
Discussion
EGFR targeted for lysosomal degradation is delivered to MVBs by a 
highly specialized process that begins with receptor ubiquitination 
and sequestration by elements of the ESCRT complex on the surface 
of early endosomes6–10. Endosomal sorting of ubiquitinated EGFR 
is initiated by ESCRT-0, which is composed of Hrs and STAM6–10. 
It has been proposed that Hrs and STAM can concentrate ubiquiti-
nated cargo on clathrin-coated microdomains of early endosomes 
and link the cargo with the subsequent ESCRT machinery that is 
required for proper sorting27,29,31. In this study, we show that LRRK1 
is required for EGFR transport from early to late endosomes. Our 
results demonstrate that LRRK1 forms a complex with EGFR via 
Grb2 and associates with STAM and Hrs in response to ligand stim-
ulation. Furthermore, we find that knockdown of LRRK1 disrupts 
the recruitment of EGFR to STAM1-positive microdomains of early 
endosomes, leading to the inhibition of EGFR sorting to the inner 
vesicles of MVBs. LRRK1 may function as a scaffolding protein 
between ubiquitinated EGFR and the Hrs–STAM1 complex. Con-
sistent with this possibility, EGFR, LRRK1 and STAM1 can form a 
ternary complex in response to EGF stimulation, and knockdown 
of LRRK1 disrupts the interaction of EGFR with STAM1. In addi-
tion, our data suggest a mechanism whereby LRRK1 modulates the 
ubiquitination status of STAM1 by direct interaction. It is likely 
that ubiquitination of STAM1, which leads to intramolecular bind-
ing within STAM1, inhibits its ability to interact with ubiquitinated 
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EGFR.  Therefore,  LRRK1  promotes  complex  formation  between 
activated EGFR and STAM1 by decreasing the ubiquitination of 
STAM1.  Our  findings  suggest  that  LRRK1  might  function  as  a 
cargo-specific factor that efficiently links the activated EGFR to the 
ESCRT machinery.
Remarkably, we find that the motility of EGF-containing early 
endosomes  is  diminished  dramatically  by  LRRK1  knockdown. 
We  demonstrate  that  LRRK1  kinase  activity  is  required  for  the 
transport of EGFR-containing early endosomes from the periph-
ery to the centre. Recent studies have shown that early endosomes   
move towards the cell centre as they mature18,20. The movement of 
early endosomes is mediated by cytoplasmic dynein, a minus end-
directed microtubule motor19,34. LRRK1 might thus be involved in 
the regulation of dynein-dependent transport of EGF-containing 
early endosomes. Interestingly, in a screen for LRRK1-binding pro-
teins, we have identified NudC and CLIP-170, which are involved 
in dynein-mediated processes35,36. Thus, LRRK1 might regulate the 
motility of EGF-containing early endosomes by phosphorylating 
these candidates.
Because excessive or inappropriate signalling by activated EGFR 
is associated with the development of a broad range of human can-
cers, the spatiotemporal regulation of EGFR trafficking by LRRK1 is 
likely to be important for the maintenance of cellular homoeostasis. 
Identification of specific LRRK1 targets involved in the regulation 
of EGFR trafficking in early endosomes will be necessary. Further 
analysis of LRRK1 function may shed new light on the molecular 
mechanisms regulating the intracellular trafficking of EGFR, and 
thus the spatiotemporal control of EGFR signalling.
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Methods
Plasmids and mutations. Human LRRK1 cDNA was subcloned into vector 
pGFP-C1 (Clontech), pCMV or pCS2. LRRK1(4PA), LRRK1(K1243M) and 
LRRK1(S625N) were generated using the QuickChange Site-Directed Mutagenesis 
Kit according to the manufacturer’s protocol (Stratagene). siRNA-resistant LRRK1 
was generated by mutating the target sequence of the LRRK1 siRNA (5′-GCAG 
GAACAGGAAAGTCACCATTTA-3′) into 5′-GTCGAAATCGAAAAGTCAC 
CATTTA-3′. Human LRRK2 (Park8) cDNA was subcloned into vector pCMV. 
HA-Grb2(P49L), HA-Grb2(S90N), HA-Grb2(G203R) and HA-Grb2(P49L/G203R) 
were generated using the mutagenesis kit described above and subcloned into 
vector pSRα37. Human Rab5 and Rab7 were subcloned into vector pGFP-C1 or 
pDsRed-C1 (Clontech; catalogue number 632466), and Rab5(Q79L) was generated 
using the mutagenesis kit described above. pDsRed-C1 produces the monomer 
form of DsRed. Deletion constructs of STAM1 were generated by PCR-based 
mutagenesis and subcloned into pCMV-Flag.
Antibodies and reagents. Rabbit antibodies against LRRK1 were produced by 
MBL (Medical and Biological Laboratories) by injecting rabbits with synthetic 
peptides corresponding to residues 1767–1783 and 1848–1865 of LRRK1 coupled 
to keyhole limpet haemocyanin. Antibodies and their suppliers were as follows: 
anti-HA (16B12, Babco); anti-Flag (M2, Sigma); anti-Myc (9E10, Santa Cruz 
Biotechnology); anti-GFP (JL-8 or Full-length polyclonal antibody, Clontech); 
anti-phospho-Tyr (4G10, Upstate Biotechnology); anti-EGFR (SC-03, Santa Cruz 
Biotechnology, LA22, Upstate Biotechnology or 6F1, MBL); anti-Grb2 (SC-23, 
Santa Cruz Biotechnology); anti-EEA1 (Clone 14, BD Transduction Laboratories); 
anti-STAM1 (H-175, Santa Cruz Biotechnology); anti-Hrs (A-5, Alexis Biochemi-
cals); anti-clathrin (clone 23, BD Transduction Laboratories); anti-Tubulin (B-5-
1-2, Sigma); Goat anti-mouse IgM conjugated to 10 nm gold (BBinternational). 
EGF-Rh and Alexa647-EGF were purchased from Molecular Probes and human 
recombinant EGF from TOYOBO.
Cell cultures and transfections. HeLa, HeLa S3, HEK293 and COS7 cells were 
cultured in Dulbecco’s modified Eagle’s medium containing 10% fetal bovine 
serum. These cells were split on 35-mm, 60-mm or 100-mm dishes at 2×105, 5×105 
or 2×106 cells per dish, respectively. After 19 h, cells were transfected using RNAi 
MAX (Invitrogen) or FuGENE 6 reagent (Roche Applied Science) according to the 
manufacturer’s protocol.
Immunoprecipitation. For immunoprecipitation, cells were lysed in RIPA buffer 
containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.25% deoxycholic acid, 1% 
NP-40, 1 mM EDTA, 2 mM dithiothreitol, 1 mM phenylmethylsulphonyl fluoride, 
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Figure 8 | Effects of LRRK1 depletion on localization of EGFR in MVBs and EGFR degradation. (a, b) Effect of LRRK1 depletion on EGFR sorting into 
the lumen of Rab5(Q79L)-induced enlarged endosomes. HeLa s3 cells treated with control (a) or LRRK1 siRnA (stealth#1) (b) were transfected with 
DsRed-Rab5(Q79L) and stimulated with 100 ng per ml of Alexa 647-EGF for 30 min. The cells were fixed and imaged by confocal microscopy. Images are 
three-dimensional reconstructions from a series of confocal Z-stack images (0.3 µm-thick sections). scale bar, 10 µm. (c, d) Confocal images from control 
(c; the boxed region in a) or LRRK1-depleted cells (d; the boxed region in b) show individual enlarged endosomes. Areas of co-localization are shown by 
line intensity profiles. (e) Quantification of Alexa 647-EGF localization into the lumen of Rab5(Q79L)-induced enlarged endosomes. Cells treated with 
control or LRRK1 siRnA (stealth#1) were co-transfected with DsRed-Rab5(Q79L) and siRnA-resistant GFP-LRRK1 (wild type and the K1243 m mutant), 
as indicated. Cells were stimulated with 100 ng per ml of Alexa 647-EGF for 30 min and then fixed. Data are presented as percentages of Alexa 647-
EGF localization into the lumen of enlarged endosomes out of the total number of Rab5(Q79L)-induced enlarged endosomes (diameter;  > 1 µm). Values 
reflect the mean s.d. of three independent experiments, with an average of 15 cells (total 100 endosomes) scored per experiment. (f) HeLa s3 cells were 
treated with control or LRRK1 siRnA (stealth#1). After 16 h of serum starvation, cells were incubated with anti-EGFR antibodies (LA-22) for 2 h at 37°C, 
followed by goat anti-mouse Igm antibodies conjugated to 10 nm gold for 1 h at 37°C. After washing to remove antibodies from the medium, the cells 
were stimulated with EGF for 10 min and then fixed. The localization of EGFR was examined by silver-enhanced immunogold electron microscopy. scale 
bar, 100 nm. (g) HeLa s3 cells treated with control or LRRK1 siRnA (stealth#1) were transfected with EGFR. After 16 h of serum starvation, cells were 
stimulated with 100 ng per ml of EGF. Cell lysates were immunoblotted with indicated antibodies. Tubulin serves as a loading control.ARTICLE     
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phosphatase inhibitor cocktail 2 (Sigma) and protease inhibitor cocktail (Sigma), 
followed by centrifugation at 15,000 g for 15 min. The supernatant was added to 
10 µl (bed volume) of protein G sepharose beads (GE Healthcare) or Dynabeads 
protein G (Invitrogen) with the indicated antibodies and rotated for 2 h at 4°C or 
for 10 min at room temperature. The beads were washed three times with ice-cold 
phosphate-buffered saline and subjected to immunoblotting or kinase assays.
Immunoblotting. After the extracts were subjected to SDS–polyacrylamide 
gel electrophoresis (SDS–PAGE), proteins were transferred to polyvinylidene 
difluoride membrane (Hybond-P, GE Healthcare). Membranes were incubated 
with indicated antibodies using the SNAP i.d. system (Millipore). Immunoreactive 
bands were detected by an HRP chemiluminescent substrate reagent kit (Novex 
ECL, Invitrogen).
In vitro autophosphorylation assay. Immunocomplex kinase reactions of GFP-
LRRK1, GFP-LRRK1(K1243M) or GFP-LRRK1(S625N) were performed in a final 
volume of 20 µl containing 20 mM Tris-HCl (pH7.4), 5 mM EGTA, 15 mM MgCl2, 
5 µCi of [γ-32P]ATP. Samples were incubated for 20 min at 30°C. Reactions were 
terminated by the addition of Laemmli sample buffer and boiling. GFP-LRRK1, 
GFP-LRRK1(K1243M) or GFP-LRRK1(S625N) was resolved by SDS–PAGE.  
Autophosphorylation of LRRK1 was detected by autoradiography.
RNA interference. siRNA targeted against human LRRK1, human Grb2 and  
negative control siRNAs were purchased from Invitrogen and Ambion. Stealth 
siRNA (Stealth#1) for human LRRK1 (target sequence: 3165gcaggaacaggaaagt 
caccattta TT), Silencer Validated siRNA (Ambion#1) for human LRRK1 (target 
sequence: 5493ggaatcactcactgactac TT) and Custom siRNA for human Grb2 
(target sequence: 607catgtttccccgcaattat TT)15 were used. Annealed siRNAs were 
transfected using RNAiMAX (Invitrogen). The transfected cells were analysed 72 h 
after transfection. For immunofluorescence experiments, cells were transfected 
with control siRNA, Grb2 siRNA or LRRK1 siRNA using RNAiMAX, incubated 
overnight and then transfected with GFP-LRRK1, GFP-Rab5, DsRed-Rab7, GFP-
Rab5(Q79L) or DsRed-Rab5(Q79L) in the indicated combinations, using FuGENE 
6 reagent (Roche Applied Science).
GTP-binding studies. Cells were lysed at 48 h post transfection in lysis buffer 
G (100 mM Tris-HCl pH 7.5, 50 mM KCl, 1 mM EDTA, 0.1 mM dithiothreitol, 
5 mM MgCl2, 1% Triton X-100) containing phosphatase inhibitor cocktail and 
protease inhibitor cocktail (Sigma) for 10 min on ice, and lysates were clarified 
by centrifugation at 15,000 g for 10 min at 4°C. Supernatants were incubated with 
20 µl of GTP-sepharose bead suspension (Sigma) by rotating at 4°C for 2 h and 
then sequentially pelleted and washed three times with 1 ml PBS. For guanine 
nucleotide competition experiments, GTP (Sigma) was added to a final concentra-
tion of 2 mM, and incubation was continued for a further 60 min at 4°C followed 
by washing. Precipitated proteins were resolved by SDS–PAGE and immunoblotted 
with anti-GFP antibodies.
Fluorescence microscopy. For immunofluorescence microscopy, cells grown 
on coverslips were treated, as indicated, and then fixed in 4% paraformaldehyde, 
permeabilized in 0.5% Triton X-100 and incubated with primary and secondary 
antibodies. Primary antibodies were anti-EEA1 at 1:100, anti-EGFR at 1:100,  
anti-STAM1 at 1:250 and anti-clathrin at 1:100. Secondary antibodies were 
Alexa-Fluor 647 goat anti-mouse IgG, Alexa-Fluor 555 goat anti-mouse IgG and 
Alexa-Fluor 488 goat anti-mouse IgG (Molecular Probes). Confocal microscopy 
was performed using an Olympus FV1000 microscope. For live-cell fluorescence 
microscopy, cells were grown in 35-mm plastic-bottomed dishes. Time-lapse im-
ages were obtained with a laser scanning confocal microscope (FV1000; Olympus). 
Tracking of GFP-Rab5- and A647-EGF-positive endosomes was conducted using 
the ‘Manual Tracking’ Image J plug-in (National Institutes of Health).
Conventional electron microscopy. Conventional electron microscopy was  
performed as described previously38. In brief, cells were fixed in 2.5% glutaralde-
hyde in 0.1 M sodium phosphate buffer at pH 7.4 for 20 min. The specimens were 
postfixed in buffer containing 1% OsO4, dehydrated in a series of graded ethanol 
solutions and embedded in epoxy resin. Ultrathin sections were collected and 
stained with uranylacetate and lead citrate and observed under an H7600  
transmission electron microscope (Hitachi). 
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